Hepatocellular Carcinoma

  • Thomas J. Devers
Part of the Current Clinical Practice book series (CCP)


Hepatocellular carcinoma (HCC) is one of the most common malignancies on a global scale, with an incidence of 20–150 cases per 100,000 population per year in some areas of Asia and Africa. It occurs much less frequently in Western Europe and the United States(1–5 cases per 100,000 population per year) (1). In a prospective study from Japan, liver cirrhosis, and viral hepatitis were implicated as risk factors for HCC, each carrying a 3-yr cumulative risk of 12.5 and 3.8%, respectively. The risk of HCC was increased almost sevenfold in patients with hepatitis B surface antigen (2) and fourfold in patients with hepatitis C antibody (3). Studies from Western Europe have confirmed a yearly incidence of 3–5% for HCC in patients with cirrhosis (4). HCC is the seventh most common form of cancer in men and the ninth most common in women worldwide (5). Each year there are 1 million new cases globally. The male prevalence is 3 times greater than female.


Hepatocellular Carcinoma Glycogen Storage Disease Percutaneous Ethanol Injection Hepatic Venous Pressure Gradient Alpha Fetoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sherlock S, Dooley J. Diseases of the Liver and Biliary System. Blackwell Scientific Publications, Oxford, 1993, p. 503.Google Scholar
  2. 2.
    Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948–963.PubMedCrossRefGoogle Scholar
  3. 3.
    Fargion S, Fracanzani AL, Piperno A. Prognostic factors for hepatocellular carcinoma in genetic hemachromatosis. Hepatology 1994;20:1426.PubMedCrossRefGoogle Scholar
  4. 4.
    Ikeda K, Saitoh S, Koida I. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Di Bisceglie, AM. Hepatitis c and hepatocellular carcinoma. Sem Liver Dis 1995; 15:64–69.CrossRefGoogle Scholar
  6. 6.
    Okuda K. Hepatocellular carcinomas associated with Hepatitis B and C virus infections: are they different? Hepatology 1995;22:1883–1885.PubMedCrossRefGoogle Scholar
  7. 7.
    Ryder SD, Koskinas J, Rizzi PM. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology 1995;22:718–722.PubMedGoogle Scholar
  8. 8.
    Chen CJ, Wang LY, Lu SN. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996;24:38–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Colombo M, DeFranchis R, Del Ninno E. Hepatocellular carcinoma in cirrhosis. N Engl J Med 1991;325:675–680.PubMedCrossRefGoogle Scholar
  10. 10.
    Liaw YF, Tai DI, Chu CM. Early detection of hepatocellular carcinoma in patients with chronic type b hepatitis. Gastroenterology 1986;90:263–267.PubMedGoogle Scholar
  11. 11.
    Oka H, Tamori A, Kuroki T. Prospective study of Alpha Fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19:61–66.PubMedCrossRefGoogle Scholar
  12. 12.
    Liebman HA, Furie BC, Tong MJ. Des gamma carboxy (abnormal) prothrombin as a marker of primary hepatocellular carcinoma. N Engl J Med 1884;310:1427–1431.CrossRefGoogle Scholar
  13. 13.
    Barbara L, Benzi G, Gaini. Natural history of untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16:132–137.PubMedCrossRefGoogle Scholar
  14. 14.
    Vauthey JN, Klimstra D, Franceschi D. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:28–34.PubMedCrossRefGoogle Scholar
  15. 15.
    Bruix J, Castells A, Bosch J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018–1022.PubMedCrossRefGoogle Scholar
  16. 16.
    Muto Y, Moriwaki H, Ninomiya M. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334:1561–1567.PubMedCrossRefGoogle Scholar
  17. 17.
    Chiu CJ, Kao HL, Wu LH. Prediction of relapse or survival after resection in human hepatomas by dna flow cytometry. J Clin Invest 1992;89:539–545.PubMedCrossRefGoogle Scholar
  18. 18.
    Kew MC. Recurrence of hepatocellular carcinoma after surgery: can it be avoided? Hepatology 1996;24:741.PubMedCrossRefGoogle Scholar
  19. 19.
    Niwa Y, Matsumura M, Shiratori Y. Quantitation of alpha fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology 1996;23:1384–1392.PubMedGoogle Scholar
  20. 20.
    Selby R, Kadry Z, Carr B. Liver transplant for hepatocellular carcinoma. World J Surg 1995;19:53–58.PubMedCrossRefGoogle Scholar
  21. 21.
    Vilana R, Bruix J, Bru C. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16:353–357.PubMedCrossRefGoogle Scholar
  22. 22.
    Manesis EK, Giannoulis G, Zoumboulis P. Treatment of hepatocellular carcinoma with combined supression and inhibition of sex hormones: a randomized, controlled trial. Hepatology 1995;21:1535–1541.PubMedGoogle Scholar
  23. 23.
    Kawata S, Yamasaki E, Nagase T. Long-term administration of pravastatin, a potent Hmg-Coa reductase inhibitor, prolongs survival of patients with advanced hepatocellular carcinoma: a randomized controlled trial. Hepatology 1996;24:245a (Abstract).Google Scholar
  24. 24.
    Nishiguchi S, Kuroki T, Nakatani S. Interferon alpha decreased the incidence of hepatocellular carcinoma in chronic active hepatitis c with cirrhosis. Lancet 1995;346:1051–1055.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Thomas J. Devers

There are no affiliations available

Personalised recommendations